Detalhe da pesquisa
1.
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
Proc Natl Acad Sci U S A
; 120(19): e2300706120, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126700
2.
Hepatocellular Carcinoma Immunotherapy.
Annu Rev Med
; 73: 267-278, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606324
3.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10415): 1835-1847, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871608
4.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499670
5.
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Invest New Drugs
; 42(1): 127-135, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270822
6.
The oncologic burden of hepatitis C virus infection: A clinical perspective.
CA Cancer J Clin
; 67(5): 411-431, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28683174
7.
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
Oncologist
; 28(8): 714-721, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952233
8.
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
Oncologist
; 2023 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159256
9.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402160
10.
Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference.
Clin Gastroenterol Hepatol
; 21(9): 2183-2192, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086825
11.
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
Am J Gastroenterol
; 118(9): 1609-1617, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307533
12.
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Hepatology
; 76(6): 1634-1648, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349735
13.
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(12): 7309-7318, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679537
14.
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Oncology
; 101(11): 730-737, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467732
15.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
16.
Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion.
HPB (Oxford)
; 25(7): 758-765, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085394
17.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798016
18.
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma.
Am J Transplant
; 22(3): 823-832, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856069
19.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
J Hepatol
; 76(4): 862-873, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902530
20.
Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study.
Hepatology
; 74(6): 3161-3173, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233041